PoliticalRepoPoliticalRepo

European Union · Record · QUESTION_WRITTEN_PRIORITY

P-9-2022-003463

COVID-19: does authorization by the Commission lead to the liability of laboratories for compensating victims of toxic side effects?

openEuropean Union· European Parliament· FR

Introduced

24 October 2022

Last action

Status

QUESTION_WRITTEN_PRIORITY

Sponsors

Subjects

Discovery layer

Source updated

24 October 2022

Records

Official record P-9-2022-003463 from European Union at European Parliament. Dated 24 October 2022. Status: QUESTION_WRITTEN_PRIORITY.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

7 official files

COVID-19: Does Commission authorisation mean that vaccine manufacturers are liable for compensating victims of toxic side effects?

View fileDownload file

  • COVID-19: Does Commission authorisation mean that vaccine manufacturers are liable for compensating victims of toxic side effects?

    QUESTION_WRITTEN_PRIORITY · EN · 17 November 2022

    ViewDownloadOpen at official source

  • COVID-19: Does Commission authorisation mean that vaccine manufacturers are liable for compensating victims of toxic side effects?

    QUESTION_WRITTEN_PRIORITY · EN · 17 November 2022

    ViewDownloadOpen at official source

  • COVID-19: Does Commission authorisation mean that vaccine manufacturers are liable for compensating victims of toxic side effects?

    QUESTION_WRITTEN_PRIORITY · EN · 17 November 2022

    DownloadOpen at official source

  • Answer

    QUESTION_WRITTEN_ANSWER

    ViewDownloadOpen at official source

  • COVID-19: l’autorisation par la Commission entraîne-t-elle la responsabilité des laboratoires pour l’indemnisation de victimes d’effets secondaires toxiques?

    QUESTION_WRITTEN_PRIORITY · FR · 17 November 2022

    ViewDownloadOpen at official source

  • COVID-19: l’autorisation par la Commission entraîne-t-elle la responsabilité des laboratoires pour l’indemnisation de victimes d’effets secondaires toxiques?

    QUESTION_WRITTEN_PRIORITY · FR · 17 November 2022

    ViewDownloadOpen at official source

  • COVID-19: l’autorisation par la Commission entraîne-t-elle la responsabilité des laboratoires pour l’indemnisation de victimes d’effets secondaires toxiques?

    QUESTION_WRITTEN_PRIORITY · FR · 17 November 2022

    DownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.